切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (06) : 859 -864. doi: 10.3877/cma.j.issn.2095-3232.2024012

临床研究

三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用
焦振东1, 惠鹏1, 金上博1,()   
  1. 1.721000 陕西省宝鸡市人民医院肝胆胰脾外科
  • 收稿日期:2024-07-11 出版日期:2024-12-10
  • 通信作者: 金上博
  • 基金资助:
    中国肝炎防治基金会天晴肝病研究基金(TQGB20210150)

Application of three-dimensional visualization combined with ICG imaging technology in laparoscopic hepatectomy for recurrent hepatocellular carcinoma

Zhendong Jiao1, Peng Hui1, Shangbo Jin1,()   

  1. 1.Department of Hepatobiliary,Pancreatic and Spleen Surgery,Baoji People's Hospital,Baoji 721000,China
  • Received:2024-07-11 Published:2024-12-10
  • Corresponding author: Shangbo Jin
引用本文:

焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.

Zhendong Jiao, Peng Hui, Shangbo Jin. Application of three-dimensional visualization combined with ICG imaging technology in laparoscopic hepatectomy for recurrent hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 859-864.

目的

探讨三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝细胞癌(肝癌)中的应用价值。

方法

回顾性分析2022年1月至2023年6月在宝鸡市人民医院接受手术的5例复发性肝癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男2例,女3例;年龄49~78岁,中位年龄66岁。术前采用计算机辅助手术系统行三维可视化肝脏重建,结合术中ICG荧光显像技术行腹腔镜肝切除术。评估该技术在复发性肝癌中应用的安全性和可行性。

结果

5例患者均顺利完成腹腔镜肝切除术,无中转开腹。平均手术时间(274±18)min,术中出血量(390±85)ml。1例患者术后出现胆漏,充分引流后治愈。术后无发生出血、腹腔感染和肝衰竭。肝切缘均阴性。术后住院时间(9.2±1.9)d。5例患者均获得随访,随访时间6~24个月,随访期间无肿瘤复发。无术后90 d内死亡病例。

结论

对于复发性肝癌腹腔镜肝切除术患者,三维可视化结合ICG荧光显像技术是安全可行的,术中操作可更精准定位肿瘤,具有创伤小、出血少等潜在的优势。

Objective

To evaluate the application value of three-dimensional visualization combined with ICG imaging in laparoscopic hepatectomy for recurrent hepatocellular carcinoma (HCC).

Methods

Clinical data of 5 patients with recurrent HCC who underwent surgery in Baoji People's Hospital from January 2022 to June 2023 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them,2 patients were male and 3 female,aged 49-78 years,with a median age of 66 years. Preoperatively,three-dimensional visualized liver reconstruction was performed by computer-aided surgical system,and combined with intraoperative ICG fluorescence imaging for laparoscopic hepatectomy. The safety and feasibility of this technology in the treatment of recurrent HCC were evaluated.

Results

All 5 patients successfully completed laparoscopic hepatectomy without conversion to open surgery. The average operation time was (274±18) min,and intraoperative blood loss was (390±85) ml. 1 patient developed postoperative bile leakage and was cured after adequate drainage. No bleeding,abdominal infection or liver failure occurred after operation. Surgical margin of the liver was negative. The length of postoperative hospital stay was (9.2±1.9) d. All 5 patients were followed up for 6-24 months,and there was no tumor recurrence during postoperative follow-up. No patient died within postoperative 90 d.

Conclusions

Three-dimensional visualization combined with ICG fluorescence imaging technology is safe and feasible for patients with recurrent HCC undergoing laparoscopic hepatectomy. Intraoperatively,it can precisely locate the tumor and has potential advantages of mild trauma and slight bleeding.

表1 复发性肝癌患者一般资料
图1 一例复发性肝癌腹腔镜肝切除术前三维可视化和术中ICG显像 注:a为术前三维可视化显示肿瘤位置,箭头为肿瘤位置;b为ICG负染显示保留部分肝脏;c为沿着染色区域行解剖性肝切除
表2 五例复发性肝癌患者术前三维可视化及术中ICG显像情况
表3 五例复发性肝癌患者术中及术后情况
[1]
Wakabayashi G,Cherqui D,Geller DA,et al. The Tokyo 2020 terminology of liver anatomy and resections: updates of the Brisbane 2000 system[J]. J Hepatobiliary Pancreat Sci,2022,29(1):6-15.
[2]
叶钢. 解剖性和非解剖性肝切除术治疗肝癌的效果[J]. 深圳中西医结合杂志,2020,30(5):126-127.
[3]
卢鹏,王宏光. 术中实时影像学引导的腹腔镜肝切除[J]. 中国医师杂志,2020,22(3):324-327.
[4]
夏永祥,张峰,李相成,等. 原发性肝癌10966例外科治疗分析[J].中华外科杂志,2021,59(1):6-17.
[5]
Zheng K,He D,Liao A,et al. Laparoscopic segmentectomy Ⅳ using hepatic round ligament approach combined with fluorescent negative staining method[J]. Ann Surg Oncol,2022,29(5):2980-2981.
[6]
刘苏来,彭创. 腹腔镜下解剖性肝Ⅷ段切除的可行性和策略[J]. 肝胆胰外科杂志,2020,32(9):513-515.
[7]
辛健,冯韦韦,何彦丰. 肝脾联合切除术与常规肝切除术治疗肝癌合并脾功能亢进患者肿瘤学效果及风险比较[J]. 中国医师进修杂志,2021,44(2):112-117.
[8]
Gotohda N,Cherqui D,Geller DA,et al. Expert Consensus Guidelines: how to safely perform minimally invasive anatomic liver resection[J]. J Hepatobiliary Pancreat Sci,2022,29(1):16-32.
[9]
Wakabayashi T,Benedetti Cacciaguerra A,Ciria R,et al. Landmarks to identify segmental borders of the liver: a review prepared for PAM-HBP expert consensus meeting 2021[J]. J Hepatobiliary Pancreat Sci,2022,29(1):82-98.
[10]
Yoshioka M,Taniai N,Kawano Y,et al. Laparoscopic repeat hepatectomy with indocyanine green fluorescence navigation: a case report[J]. Nippon Ika Daigaku Zasshi,2019,86(5):291-295.
[11]
曾宁,曾思略,杨剑,等. 增强现实导航技术联合吲哚菁绿分子荧光影像在肝门部胆管癌根治术中应用研究[J]. 中国实用外科杂志,2020,40(12):1413-1418.
[12]
武文华,冯秦辉,蔡芝芳,等. 经导管动脉化疗栓塞术联合超声引导射频消融术治疗原发性肝癌对疗效及免疫功能的影响[J]. 中国医师进修杂志,2022,45(5):459-464.
[13]
刘凯,彭江,何自力. 实时超声导航下解剖性肝段切除应用于原发性肝癌治疗中的价值[J]. 中国医师杂志,2022,24(2):212-215.
[14]
Wakabayashi T,Cacciaguerra AB,Abe Y,et al. Indocyanine green fluorescence navigation in liver surgery: a systematic review on dose and timing of administration[J]. Ann Surg,2022,275(6):1025-1034.
[15]
Funamizu N,Ozaki T,Mishima K,et al. Evaluation of accuracy of laparoscopic liver mono-segmentectomy using the Glissonian approach with indocyanine green fluorescence negative staining by comparing estimated and actual resection volumes: a single-center retrospective cohort study[J]. J Hepatobiliary Pancreat Sci,2021,28(12):1060-1068.
[16]
赵学勤,朴纪颖,张秉武,等. 腹腔镜解剖性肝切除术与非解剖性肝切除术的前瞻性对比研究[J/OL]. 中华普外科手术学杂志(电子版),2020,14(6):581-584.
[17]
Chiow AKH,Rho SY,Wee IJY,et al. Robotic ICG guided anatomical liver resection in a multi-centre cohort: an evolution from "positive staining" into "negative staining" method[J]. HPB,2021,23(12):475-482.
[18]
华建军,王兴. 实时超声导航下解剖性肝段切除术治疗原发性肝癌的临床效果及对术后生活质量、复发率的影响[J]. 临床医学研究与实践,2020,5(5):56-58.
[19]
张成武. 腹腔镜解剖性肝切除术的若干进展[J]. 肝胆胰外科杂志,2020,32(3):129-132,147.
[20]
谭万岱. 解剖性肝切除术对原发性肝癌的治疗效果及安全性分析[J]. 中国社区医师,2020,36(32):62-63.
[21]
Alomari MAM,Wakabayashi T,Colella M,et al. Comparing the accuracy of positive and negative indocyanine green staining in guiding laparoscopic anatomical liver resection: protocol for a randomised controlled trial[J]. BMJ Open,2023,13(9):e072926.
[22]
张志刚,姜耕,唐羿,等. 手术治疗与介入治疗对晚期复发性肝癌患者预后、纤维化指标及下肢静脉血栓形成的影响[J]. 血管与腔内血管外科杂志,2023,9(1):104-107,117.
[23]
丛鹏,屈岳育,胡韬,等. 腹腔镜肝切除术中剔肝法联合术中超声加荧光显影技术对肝脏复杂占位性病变的临床疗效[J]. 重庆医学,2021,50(S2):316-318.
[24]
洪汉崟,陈志坚,池小斌,等. 鞘外法和鞘内法Glisson蒂阻断在腹腔镜解剖性肝切除中应用的对比研究[J/OL]. 中华肝脏外科手术学电子杂志,2024,13(1):21-26.
[25]
程聪,陆马乘,张烨. 三维可视化技术辅助肝癌腹腔镜手术的有效性和安全性的Meta分析[J]. 医疗卫生装备,2023,44(8):79-84.
[26]
周毅,余继海,张传海,等. 吲哚菁绿荧光联合三维可视化技术应用于腹腔镜肝脏血管瘤切除[J]. 肝胆外科杂志,2022,30(1):29-32.
[1] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[2] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[3] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[4] 王兴, 文阳辉, 姚戈冰, 郭平学, 杨自华. ICG荧光腹腔镜下胆囊切除术的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 663-666.
[5] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[6] 白浪, 张雪玉, 白铁成, 贺爱军. 腹腔镜近端胃切除术中圆锥形重叠吻合成形术对Siewert Ⅱ型AEG患者胃食管反流、营养状态的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 679-682.
[7] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[8] 张朝军, 袁新普. 腹腔镜辅助低位直肠癌根治术[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 602-602.
[9] 郑民华, 蒋天宇, 赵轩, 马君俊. 中国腹腔镜直肠癌根治术30年发展历程与未来[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 591-595.
[10] 池畔, 黄胜辉. 中国腹腔镜直肠癌根治术30年来的巨大进步[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 596-600.
[11] 李艳丽, 李迎晔, 林英立. 后腹腔镜单层面右肾上腺嗜铬细胞瘤切除术[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 656-656.
[12] 江东根, 依力夏提·艾力, 依布拉音江·阿布力克木等. 基层医院单一术者改良单通道腹腔镜下鞘状突环扎术学习曲线及体会[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 560-565.
[13] 王万里, 郭兵, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-.
阅读次数
全文


摘要